Table 6.
Treatment | Sex | |
|
(ml) |
|
|
||
---|---|---|---|---|---|---|---|---|
1stWeek | 2ndWeek | 3stWeek | 4stWeek | 5thWeek | 6thWeek | |||
Control (0.5% CMC) |
M(n=5) |
100.80±12.45 |
101.00±15.37 |
100.40±6.96 |
100.80±11.34 |
|||
F (n=5) |
98.40±5.53 |
101. 00±11.05 |
101.80±12.68 |
101.40±13.95 |
||||
MF(n=10) |
99.60±6.43 |
101.00±8.92 |
101.10±6.82 |
101.10±8.48 |
||||
NK |
(300 mg/kg p.o/day) |
M(n=5) |
99.40±11.42 |
100. 20±9.61 |
101.20±16.83 |
100.60±13.67 |
||
F (n=5) |
101.60±5.71 |
101.40±11.28 |
100.60±9.09 |
101.60±11.51 |
||||
MF(n=10) |
100.50±6.03 |
100.80±6.99 |
100.90±9.02 |
101.10±8.42 |
||||
(600 mg/kg p.o/day) |
M(n=5) |
98.80±11.89 |
101.80±9.05 |
101.00±19.24 |
100.80±14.37 |
|||
F (n=5) |
100.00±7.29 |
100.80±8.00 |
102.20±17.30 |
100.40±11.21 |
||||
MF(n=10) |
99.40±6.58 |
101.30±5.70 |
101.60±12.20 |
100.60±8.59 |
||||
(900 mg/kg p.o/day) |
M(n=5) |
99.80±9.61 |
100.40±5.35 |
100.20±9.44 |
98.80±7.00 |
|||
F (n=5) |
100.20±12.48 |
99.80±6.97 |
99.60±6.10 |
101.20±16.49 |
||||
MF(n=10) |
100.00±7.43 |
100. 10±4.14 |
99.90±5.30 |
100.00±8.45 |
||||
Satellite group | ||||||||
Control (0.5% CMC) |
M(n=5) |
101.60±8.35 |
102.60±7.12 |
100.80±15.63 |
102.40±13.55 |
101.40±10.62 |
100.40±19.44 |
|
F (n=5) |
99.40±4.15 |
100.20±5.84 |
100.00±10.43 |
99.00±5.55 |
100.40±8.44 |
101.60±18.25 |
||
MF(n=10) |
100.50±4.41 |
101.40±4.36 |
100.40±8.86 |
100.70±6.93 |
100.90±6.40 |
101.00±12.57 |
||
NK (900 mg/kg p.o/day) | M(n=5) |
101.60±8.39 |
101.40±10.63 |
101.60±14.66 |
101.20±4.04 |
102.40±11.78 |
101.60±10.80 |
|
F (n=5) |
99.40±13.01 |
99.80±8.26 |
100.60±11.29 |
101.60±11.71 |
101.00±14.32 |
102.20±12.29 |
||
MF(n=10) | 100.50±7.31 | 100.60±6.35 | 101.10±08.72 | 101.40±5.84 | 101.70±8.74 | 101.90±7.71 |
Values expressed as mean ± SEM; ml – milleliters; Significance with Tukey’s test following one way ANOVA is evaluated as *p < 0.05 and **p < 0.01 vs control group.